Here, we documented that a complementary approach promoting the metabolic use of endogenous Glut is beneficial against PD‐related injury and may have therapeutic potential because it can simultaneously address two key issues at once: Glut‐mediated excitotoxicity and the upstream energetic failure. The gene discussed is SLC2A1; the disease is Parkinson disease.